BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37078050)

  • 1. Quantifying the drug response of patient-derived organoid clusters by aggregated morphological indicators with multi-parameters based on optical coherence tomography.
    Zhang L; Wang L; Yang S; He K; Bao D; Xu M
    Biomed Opt Express; 2023 Apr; 14(4):1703-1717. PubMed ID: 37078050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated detection and growth tracking of 3D bio-printed organoid clusters using optical coherence tomography with deep convolutional neural networks.
    Bao D; Wang L; Zhou X; Yang S; He K; Xu M
    Front Bioeng Biotechnol; 2023; 11():1133090. PubMed ID: 37122853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening.
    Deben C; De La Hoz EC; Compte ML; Van Schil P; Hendriks JMH; Lauwers P; Yogeswaran SK; Lardon F; Pauwels P; Van Laere S; Bogaerts A; Smits E; Vanlanduit S; Lin A
    Cell Oncol (Dordr); 2023 Apr; 46(2):299-314. PubMed ID: 36508089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic characteristics and drug screening among organoids derived from non-small cell lung cancer patients.
    Chen JH; Chu XP; Zhang JT; Nie Q; Tang WF; Su J; Yan HH; Zheng HP; Chen ZX; Chen X; Song MM; Yi X; Li PS; Guan YF; Li G; Deng CX; Rosell R; Wu YL; Zhong WZ
    Thorac Cancer; 2020 Aug; 11(8):2279-2290. PubMed ID: 32633046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volumetric growth tracking of patient-derived cancer organoids using optical coherence tomography.
    Gil DA; Deming DA; Skala MC
    Biomed Opt Express; 2021 Jul; 12(7):3789-3805. PubMed ID: 34457380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-derived organoid culture of gastric cancer for disease modeling and drug sensitivity testing.
    Zu M; Hao X; Ning J; Zhou X; Gong Y; Lang Y; Xu W; Zhang J; Ding S
    Biomed Pharmacother; 2023 Jul; 163():114751. PubMed ID: 37105073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of Human Pituitary Neuroendocrine Tumor Derived Organoid and Its Pilot Application for Drug Screening.
    Cui R; Duan H; Hu W; Li C; Zhong S; Liang L; Chen S; Hu H; He Z; Wang Z; Guo X; Chen Z; Xu C; Zhu Y; Chen Y; Sai K; Yang Q; Guo C; Mou Y; Jiang X
    J Clin Endocrinol Metab; 2024 Apr; ():. PubMed ID: 38656317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues.
    Gao M; Lin M; Rao M; Thompson H; Hirai K; Choi M; Georgakis GV; Sasson AR; Bucobo JC; Tzimas D; D'Souza LS; Buscaglia JM; Davis J; Shroyer KR; Li J; Powers S; Kim J
    Ann Surg Oncol; 2018 Sep; 25(9):2767-2775. PubMed ID: 30003451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-Derived Organoid Serves as a Platform for Personalized Chemotherapy in Advanced Colorectal Cancer Patients.
    Geevimaan K; Guo JY; Shen CN; Jiang JK; Fann CSJ; Hwang MJ; Shui JW; Lin HT; Wang MJ; Shih HC; Li AF; Chang SC; Yang SH; Chen JY
    Front Oncol; 2022; 12():883437. PubMed ID: 35719949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Cell and Organoid-Level Analysis of Patient-Derived 3D Organoids to Evaluate Tumor Cell Growth Dynamics and Drug Response.
    Kim S; Choung S; Sun RX; Ung N; Hashemi N; Fong EJ; Lau R; Spiller E; Gasho J; Foo J; Mumenthaler SM
    SLAS Discov; 2020 Aug; 25(7):744-754. PubMed ID: 32349587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel deep learning segmentation model for organoid-based drug screening.
    Wang X; Wu C; Zhang S; Yu P; Li L; Guo C; Li R
    Front Pharmacol; 2022; 13():1080273. PubMed ID: 36588731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effect of luteolin proven by patient-derived organoids of gastric cancer.
    Hao X; Zu M; Ning J; Zhou X; Gong Y; Han X; Meng Q; Li D; Ding S
    Phytother Res; 2023 Nov; 37(11):5315-5327. PubMed ID: 37469042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of patient-derived organoids and a characterization-based drug discovery platform for treatment of pancreatic cancer.
    Watanabe S; Yogo A; Otsubo T; Umehara H; Oishi J; Kodo T; Masui T; Takaishi S; Seno H; Uemoto S; Hatano E
    BMC Cancer; 2022 May; 22(1):489. PubMed ID: 35505283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens.
    Servant R; Garioni M; Vlajnic T; Blind M; Pueschel H; Müller DC; Zellweger T; Templeton AJ; Garofoli A; Maletti S; Piscuoglio S; Rubin MA; Seifert H; Rentsch CA; Bubendorf L; Le Magnen C
    J Pathol; 2021 Aug; 254(5):543-555. PubMed ID: 33934365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An In Vitro System for Evaluating Molecular Targeted Drugs Using Lung Patient-Derived Tumor Organoids.
    Takahashi N; Hoshi H; Higa A; Hiyama G; Tamura H; Ogawa M; Takagi K; Goda K; Okabe N; Muto S; Suzuki H; Shimomura K; Watanabe S; Takagi M
    Cells; 2019 May; 8(5):. PubMed ID: 31137590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing.
    Fashemi BE; van Biljon L; Rodriguez J; Graham O; Mullen M; Khabele D
    J Vis Exp; 2023 Sep; (199):. PubMed ID: 37782106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-derived organoids of non-small cells lung cancer and their application for drug screening.
    Li YF; Gao Y; Liang BW; Cao XQ; Sun ZJ; Yu JH; Liu ZD; Han Y
    Neoplasma; 2020 Mar; 67(2):430-437. PubMed ID: 31973535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction".
    Papaccio F; García-Mico B; Gimeno-Valiente F; Cabeza-Segura M; Gambardella V; Gutiérrez-Bravo MF; Alfaro-Cervelló C; Martinez-Ciarpaglini C; Rentero-Garrido P; Zúñiga-Trejos S; Carbonell-Asins JA; Fleitas T; Roselló S; Huerta M; Sánchez Del Pino MM; Sabater L; Roda D; Tarazona N; Cervantes A; Castillo J
    J Exp Clin Cancer Res; 2023 Jan; 42(1):8. PubMed ID: 36604765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic Cancer.
    Grossman JE; Muthuswamy L; Huang L; Akshinthala D; Perea S; Gonzalez RS; Tsai LL; Cohen J; Bockorny B; Bullock AJ; Schlechter B; Peters MLB; Conahan C; Narasimhan S; Lim C; Davis RB; Besaw R; Sawhney MS; Pleskow D; Berzin TM; Smith M; Kent TS; Callery M; Muthuswamy SK; Hidalgo M
    Clin Cancer Res; 2022 Feb; 28(4):708-718. PubMed ID: 34789479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.